1. Home
  2. |Insights
  3. |Only One Place to Go for In-sourcing Challenge

Only One Place to Go for In-sourcing Challenge

Client Alert | less than 1 min read | 04.14.14

In Fisher-Cal Indus., Inc. v. U.S. (Apr. 8, 2014), the D.C. Circuit bounced an incumbent's challenge to the agency's in-sourcing decision. Finding the decision to be part of the procurement process, the court ruled that it was, in essence, a bid protest that could be brought only in the Court of Federal Claims.


Insights

Client Alert | 3 min read | 11.17.26

CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs

On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.  ...